Venous Disease
 
line
   
 
line
 
 
   
line
 
 
   
 

SERDIA is a leading company in the field of phlebology since more than a decade and is dedicated to increasing knowledge and recognition of venous disease in India.

SERDIA has significantly contributed to increasing the awareness of epidemiology, pathophysiology and management of venous insufficiency through well sought clinical studies such as the RELIEF study. SERVIER the parent company of SERDIA, has been a pioneer in research into the mechanistic aspects of venous disease linked to the pathology, clinical manifestations and pharmacological studies. This is evident by the fact that Daflon 500, the only reference phlebotrophic, is a worldwide leader in the treatment of chronic venous insufficiency.

SERDIA’s presence is largely felt at major scientific congresses in the field of phlebology, organized by National and International scientific societies. Some of the National meetings in which SERDIA actively participate are VSICON (Annual Conference of Vascular Surgeons of India), AOGI (Annual Congress of Obstetrics and Gynaecology Society of India), DOGS (Annual Conference of Obstetrics and Gynaecology Society of Delhi) and APICON (Annual Conference of Association of Physicians of India) to mention a few of them. Some of the International meetings include the prestigious Union International de Phlébologie, International Union of Angiology, European Venous Forum and Latin American Venous Forum.

In the field of colo-proctology SERDIA’s contribution is worth a mention in making the management of haemorrhoidal disease much more convenient. This is also evident by some interesting clinical studies conducted by SERDIA at the All India Institute of Medical Sciences, New Delhi.

SERVIER, the parent company of SERDIA is a partner of the Union Internationale de Phlébologie (UIP). Every second year Servier sponsors the Servier Research Fellowship, awarded by the Research Fund of the Union Internationale de Phlébologie. This important fund is open to young researchers who have a specific interest in the fields of phlebology and lymphology. The Servier Research Fellowship provides a 30,000 USD grant for 2 years’ work on a research project selected through a highly competitive peer-review procedure. For more details click here

SERDIA, as always, will be involved in the field of phlebology with the main thrust of fostering the awareness, recognition and management of all the implications of venous disease.

 
top
© 2002 - 2003 SERDIA PHARMACEUTICALS (INDIA) PVT. LTD. -  All Rights Reserved - Terms of Use
SERDIA does not sell its products over the Internet - More information
Site developed and maintained by E Vision Technologies